{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:53:35Z","timestamp":1792011215598,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pathol.2026.08.014","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:33:31Z","timestamp":1790033611000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of genomic testing in modern diagnostic surgical pathology practice"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-8745","authenticated-orcid":false,"given":"Pranav","family":"Dorwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7968-1846","authenticated-orcid":false,"given":"Laurence A.","family":"Galea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-0834","authenticated-orcid":false,"given":"Laveniya","family":"Satgunaseelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-6052","authenticated-orcid":false,"given":"David","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9578-2612","authenticated-orcid":false,"given":"Ali","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-3356","authenticated-orcid":false,"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arivarasan","family":"Karunamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2582-4026","authenticated-orcid":false,"given":"King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-2368","authenticated-orcid":false,"given":"Fiona","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beena","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.08.014_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-016-2025-7","article-title":"Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL","volume":"470","author":"Deans","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2026.08.014_bib2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pathol.2026.08.014_bib3","series-title":"Soft tissue and bone tumours","year":"2020"},{"key":"10.1016\/j.pathol.2026.08.014_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00428-024-03736-5","article-title":"Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors","volume":"484","author":"de \u00c1lava","year":"2024","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2026.08.014_bib5","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3390\/genes14122229","article-title":"Soft tissue and bone tumor diagnostics: harnessing the power of molecular techniques","volume":"14","author":"Cordier","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pathol.2026.08.014_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2023.05.012","article-title":"Cellular myofibromas with SRF fusions: clinicopathological and molecular study of 3 cases of a rare entity and a potential mimic of sarcoma","volume":"138","author":"Papa","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ng0894-502","article-title":"Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11. 2;q11. 2) translocation found in human synovial sarcoma","volume":"7","author":"Clark","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PDM.0b013e3181a06f66","article-title":"Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR","volume":"18","author":"Machado","year":"2009","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/pin.13373","article-title":"A novel FET-ETS family fusion (FUS:: FLI1) in a case of Ewing sarcoma","volume":"73","author":"Dorwal","year":"2023","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2026.08.014_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2023.12.004","article-title":"Rhabdomyosarcoma: updates on classification and the necessity of molecular testing beyond immunohistochemistry","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/363640a0","article-title":"Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma","volume":"363","author":"Crozat","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2026.08.014_bib12","first-page":"489","article-title":"Fusion of the EWS and CHOP genes in myxoid liposarcoma","volume":"12","author":"Panagopoulos","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2026.08.014_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/gcc.20937","article-title":"Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data","volume":"51","author":"Wang","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2026.08.014_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.10202","article-title":"Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment","volume":"37","author":"Sirvent","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2026.08.014_bib15","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3390\/diagnostics11122326","article-title":"Molecular classification of soft tissue and bone tumors","volume":"11","author":"Creytens","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.pathol.2026.08.014_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00428-018-2350-0","article-title":"Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of USP6 gene rearrangements","volume":"473","author":"Erber","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2026.08.014_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.70164","article-title":"Small nucleotide variant analysis using RNA fusion panel (SMURF): making the most of RNAseq data in solid tumours","volume":"40","author":"Dorwal","year":"2026","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.pathol.2026.08.014_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2559.2011.03932.x","article-title":"'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis","volume":"59","author":"Colombo","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib19","first-page":"1055","article-title":"Effect of decalcification protocols on immunohistochemistry and molecular analyses in bone samples","volume":"34","author":"Alers","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00256-016-2373-z","article-title":"Symplastic\/pseudoanaplastic giant cell tumor of the bone","volume":"45","author":"Sarungbam","year":"2016","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.pathol.2026.08.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00256-026-05167-6","article-title":"Primary malignant aneurysmal bone cyst of the metatarsal with PAFAH1B1::USP6 fusion: expanding the clinicopathologic spectrum of malignant USP6 translocated neoplasms","volume":"55","author":"Bennett","year":"2026","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.pathol.2026.08.014_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00292-018-0417-y","article-title":"The activating GNAS mutation: a survey of fibrous dysplasia, its associated syndromes, and other skeletal and extraskeletal lesions","volume":"39","author":"Ostertag","year":"2018","journal-title":"Pathologe"},{"key":"10.1016\/j.pathol.2026.08.014_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4132\/jptm.2023.03.20","article-title":"What\u2019s new in bone and soft tissue pathology 2023: guidelines for molecular testing","volume":"57","author":"Obeidin","year":"2023","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.pathol.2026.08.014_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0000000000002381","article-title":"A clinical, morphologic, and molecular comparison of Bonafide Spitz Melanomas and atypical spitz tumors in the pediatric population","volume":"49","author":"Beydoun","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pathol.2022.12.001","article-title":"An update on genomic aberrations in Spitz naevi and tumours","volume":"55","author":"Hagstrom","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100286","article-title":"Histologic and genetic features of 51 melanocytic neoplasms with protein kinase C fusion genes","volume":"36","author":"de la Fouchardi\u00e8re","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41379-021-00976-7","article-title":"Novel insights into the BAP1-inactivated melanocytic tumor","volume":"35","author":"Donati","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jmoldx.2022.08.004","article-title":"Single-nucleotide polymorphism array for histologically ambiguous melanocytic tumors","volume":"24","author":"Geiersbach","year":"2022","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.pathol.2026.08.014_bib30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/PAS.0000000000002575","article-title":"Clinical outcomes and prognostication of CRTC1:: TRIM11 fusion cutaneous tumors","volume":"50","author":"Trichy","year":"2026","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.pathol.2025.05.002","article-title":"GAB1::ABL1 fusion-associated spindle cell neoplasm: expanding our knowledge of kinase-rearranged spindle cell tumours","volume":"57","author":"Dorwal","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib32","series-title":"WHO classification of tumours of the central nervous system","year":"2016"},{"key":"10.1016\/j.pathol.2026.08.014_bib33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pathol.2026.08.014_bib34","first-page":"1175","article-title":"Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p","volume":"145","author":"Reifenberger","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pathol.2026.08.014_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","article-title":"Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes","volume":"130","author":"Castel","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2026.08.014_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00401-020-02127-9","article-title":"cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas","volume":"139","author":"Brat","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2026.08.014_bib41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2026.08.014_bib42","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","article-title":"Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas","volume":"10","author":"Guerreiro Stucklin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2026.08.014_bib43","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pathol.2026.08.014_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pathol.2026.08.014_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bpa.12524","article-title":"Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis","volume":"28","author":"Tauziede-Espariat","year":"2018","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/neuonc\/nox094","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pathol.2026.08.014_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/neuonc\/noae170","article-title":"cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pathol.2026.08.014_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0314592","article-title":"Trends in childhood cancer: incidence and survival analysis over 45 years of SEER data","volume":"20","author":"Sultan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2026.08.014_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.2287","article-title":"The pediatric cancer genome project","volume":"44","author":"Downing","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.omtn.2017.01.005","article-title":"Relevance of fusion genes in pediatric cancers: toward precision medicine","volume":"6","author":"Dupain","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.pathol.2026.08.014_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.747895","article-title":"Molecular targets for novel therapeutics in pediatric fusion-positive non-CNS solid tumors","volume":"12","author":"Chang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pathol.2026.08.014_bib53","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41591-020-1072-4","article-title":"Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer","volume":"26","author":"Wong","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2026.08.014_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009231","article-title":"Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer-prone syndromes","volume":"16","author":"Byrjalsen","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib55","series-title":"WHO Classification of Tumours Editorial Board. Urinary and male genital tumours","article-title":"Tumours of the kidney","author":"Amin","year":"2022"},{"key":"10.1016\/j.pathol.2026.08.014_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/10668969221108517","article-title":"TFE3 rearrangement and expression in renal cell carcinoma","volume":"31","author":"Kmeid","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/his.15560","article-title":"MiT family translocation carcinomas of the kidney and related entities","volume":"88","author":"Argani","year":"2026","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib58","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/cancers18060958","article-title":"TFE3-rearranged and TFEB-altered renal cell carcinomas: molecular landscape and therapeutic advances","volume":"18","author":"Portu","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2026.08.014_bib59","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/PAS.0b013e3182613d8f","article-title":"Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum","volume":"36","author":"Argani","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib60","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0002-9440(10)64680-9","article-title":"A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation","volume":"158","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib61","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/hmg\/ddg178","article-title":"Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution","volume":"12","author":"Kuiper","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib62","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euf.2019.11.013","article-title":"Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course","volume":"7","author":"DiNatale","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2026.08.014_bib64","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.pathol.2026.08.014_bib65","article-title":"Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: a comparison of fumarate hydratase (FH) and S-(2-succino)-cysteine (2SC) immunohistochemistry as ancillary tools","volume":"28","author":"Chen","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib66","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2022.12.013","article-title":"Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma","volume":"134","author":"Mannan","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib67","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase-deficient renal carcinoma: a morphologically distinct entity. A clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib68","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.08.014_bib69","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK-rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2559.2012.04228.x","article-title":"SMARCB1\/INI1 inactivation in renal medullary carcinoma","volume":"61","author":"Calderaro","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib71","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/PAP.0000000000000426","article-title":"Update on selected high-grade renal cell carcinomas of the kidney: FH-deficient, ALK-rearranged, and medullary carcinomas","volume":"31","author":"Chen","year":"2024","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2026.08.014_bib73","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2014-03-564583","article-title":"C1013G\/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma","volume":"123","author":"Roccaro","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.08.014_bib74","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.08.014_bib75","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.08.014_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","article-title":"Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients","volume":"131","author":"Berg","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-023-03590-x","article-title":"Emerging entities: high-grade\/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2026.08.014_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-026-04428-y","article-title":"Targeted panel sequencing for refining B-cell lymphoma diagnosis: a real-life, reference center experience","volume":"488","author":"B\u00f6ck","year":"2026","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2026.08.014_bib79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T-cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib80","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.08.014_bib81","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma, NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.08.014_bib82","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12094-023-03307-1","article-title":"A genetic profiling guideline to support diagnosis and clinical management of lymphomas","volume":"26","author":"S\u00e1nchez-Beato","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.pathol.2026.08.014_bib83","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma","volume":"108","author":"Qiu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2026.08.014_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105671","article-title":"Systemic ALK-negative anaplastic large cell lymphoma: insights into morphologic, immunophenotypic, genetic and molecular characteristics","volume":"156","author":"Xie","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib85","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2026.08.014_bib86","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.aag0299","article-title":"Mutational signatures associated with tobacco smoking in human cancer","volume":"354","author":"Alexandrov","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.pathol.2026.08.014_bib87","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/s41379-020-0594-0","article-title":"Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma","volume":"33","author":"Yang","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.08.014_bib88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-genet-072920-035840","article-title":"APOBEC-induced mutagenesis in cancer","volume":"56","author":"Mertz","year":"2022","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.pathol.2026.08.014_bib89","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pin.70035","article-title":"Uterine mesenchymal neoplasm with a novel CDC42::PLAG1 fusion","volume":"75","author":"Dorwal","year":"2025","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2026.08.014_bib90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pathol.2025.08.013","article-title":"Uterine mesenchymal tumour with KAT6B::KANSL1 fusion: a new clinically significant diagnostic entity","volume":"58","author":"Uivaa","year":"2026","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib91","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.pathol.2025.01.006","article-title":"Myoepithelial carcinoma ex-pleomorphic adenoma of the parotid gland: a rare case with FGFR1::PLAG1 fusion, and a brief review of the literature","volume":"57","author":"Papa","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.08.014_bib92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12022-022-09747-9","article-title":"The presence of typical BRAFV600E-like atypia in papillary thyroid carcinoma is highly specific for the presence of the BRAFV600E mutation","volume":"34","author":"Turchini","year":"2023","journal-title":"Endocr Pathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526006513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526006513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:39:10Z","timestamp":1792010350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526006513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":92,"alternative-id":["S0031302526006513"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.08.014","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of genomic testing in modern diagnostic surgical pathology practice","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}